What does this research mean for the field?

Antiplatelet therapy significantly reduces 30-day all-cause mortality in patients with bloodstream infection without increasing the risk of bleeding. Novelty: ClaimNovelty.NOVEL_FINDING. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

This research aims to investigate the effect of antiplatelet therapy on mortality rates in patients with bloodstream infections.

March 4, 2026European journal of medical research0 citationsOpen Access

Antiplatelet therapy is associated with reduced mortality in patients with bloodstream infection: a propensity score-matched cohort study

SSSijing SunCapital University MDMengxi DingXian Central Hospital BYBin YanCapital University

Key Points

This research aims to investigate the effect of antiplatelet therapy on mortality rates in patients with bloodstream infections.
Cohort study design
Included patients with bloodstream infection
Used propensity score matching to control for biases
Antiplatelet therapy significantly reduced 30-day all-cause mortality
No increased risk of bleeding observed

Abstract

In patients with BSI, antiplatelet therapy significantly reduced 30-day all-cause mortality without an increasing risk of bleeding.

اسأل الذكاء الاصطناعي

Bookmark

View Full Paper